메뉴 건너뛰기




Volumn 9, Issue , 2016, Pages 27-37

Probiotics are effective at preventing Clostridium difficile-associated diarrhea: A systematic review and meta-analysis

Author keywords

Antibiotic associated diarrhea; Clostridium difficile associated diarrhea; Probiotics

Indexed keywords

PROBIOTIC AGENT;

EID: 84959483325     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S98280     Document Type: Article
Times cited : (140)

References (63)
  • 1
    • 84912016691 scopus 로고    scopus 로고
    • The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection
    • Sun X, Hirota SA. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection. Mol Immunol. 2015;63:193-202.
    • (2015) Mol Immunol. , vol.63 , pp. 193-202
    • Sun, X.1    Hirota, S.A.2
  • 2
    • 80053253206 scopus 로고    scopus 로고
    • Biology of Clostridium difficile : Implications for epidemiology and diagnosis
    • Carroll KC, Bartlett JG. Biology of Clostridium difficile : implications for epidemiology and diagnosis. Annu Rev Microbiol. 2011;65:501-521.
    • (2011) Annu Rev Microbiol. , vol.65 , pp. 501-521
    • Carroll, K.C.1    Bartlett, J.G.2
  • 3
    • 0036467063 scopus 로고    scopus 로고
    • Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile
    • Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346-353.
    • (2002) Clin Infect Dis. , vol.34 , pp. 346-353
    • Kyne, L.1    Hamel, M.B.2    Polavaram, R.3    Kelly, C.P.4
  • 4
    • 35348962496 scopus 로고    scopus 로고
    • The emerging infectious challenge of Clostridium difficile -associated disease in Massachusetts hospitals: Clinical and economic consequences
    • O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile -associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007;28:1219-1227.
    • (2007) Infect Control Hosp Epidemiol. , vol.28 , pp. 1219-1227
    • O’Brien, J.A.1    Lahue, B.J.2    Caro, J.J.3    Davidson, D.M.4
  • 5
    • 0030726256 scopus 로고    scopus 로고
    • Clostridium difficile -associated diarrhea in HIV-infected patients: Epidemiology and risk factors
    • Barbut F, Meynard JL, Guiguet M, et al. Clostridium difficile -associated diarrhea in HIV-infected patients: epidemiology and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:176-181.
    • (1997) J Acquir Immune Defic Syndr Hum Retrovirol. , vol.16 , pp. 176-181
    • Barbut, F.1    Meynard, J.L.2    Guiguet, M.3
  • 6
    • 0035436311 scopus 로고    scopus 로고
    • Epidemiology of Clostridium difficile -associated infections
    • Barbut F, Petit JC. Epidemiology of Clostridium difficile -associated infections. Clin Microbiol Infect. 2001;7:405-410.
    • (2001) Clin Microbiol Infect. , vol.7 , pp. 405-410
    • Barbut, F.1    Petit, J.C.2
  • 8
    • 0027423999 scopus 로고
    • Risk factors for Clostridium difficile -associated diarrhoea in HIV-infected patients
    • Hutin Y, Molina JM, Casin I, et al. Risk factors for Clostridium difficile -associated diarrhoea in HIV-infected patients. AIDS. 1993;7: 1441-1447.
    • (1993) AIDS. , vol.7 , pp. 1441-1447
    • Hutin, Y.1    Molina, J.M.2    Casin, I.3
  • 9
    • 80455173556 scopus 로고    scopus 로고
    • Host and pathogen factors for Clostridium difficile infection and colonization
    • Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365:1693-1703.
    • (2011) N Engl J Med. , vol.365 , pp. 1693-1703
    • Loo, V.G.1    Bourgault, A.M.2    Poirier, L.3
  • 10
    • 84896454372 scopus 로고    scopus 로고
    • Medication risk factors associated with healthcare-associated Clostridium difficile infection: A multilevel model case-control study among 64 US academic medical centres
    • Pakyz AL, Jawahar R, Wang Q, Harpe SE. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres. J Antimicrob Chemother. 2014;69:1127-1131.
    • (2014) J Antimicrob Chemother. , vol.69 , pp. 1127-1131
    • Pakyz, A.L.1    Jawahar, R.2    Wang, Q.3    Harpe, S.E.4
  • 11
    • 84876236060 scopus 로고    scopus 로고
    • Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection
    • Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57:2326-2332.
    • (2013) Antimicrob Agents Chemother. , vol.57 , pp. 2326-2332
    • Brown, K.A.1    Khanafer, N.2    Daneman, N.3    Fisman, D.N.4
  • 12
    • 0034452451 scopus 로고    scopus 로고
    • Environmental control to reduce transmission of Clostridium difficile
    • Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31: 995-1000.
    • (2000) Clin Infect Dis. , vol.31 , pp. 995-1000
    • Mayfield, J.L.1    Leet, T.2    Miller, J.3    Mundy, L.M.4
  • 13
    • 84867484375 scopus 로고    scopus 로고
    • Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections
    • Rupp ME, Cavalieri RJ, Lyden E, et al. Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections. Infect Control Hosp Epidemiol. 2012;33:1094-1100.
    • (2012) Infect Control Hosp Epidemiol. , vol.33 , pp. 1094-1100
    • Rupp, M.E.1    Cavalieri, R.J.2    Lyden, E.3
  • 15
    • 84862293439 scopus 로고    scopus 로고
    • World Gastroenterology Organisation Global Guidelines: Probiotics and prebiotics October 2011
    • Guarner F, Khan AG, Garisch J, et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol. 2012;46:468-481.
    • (2012) J Clin Gastroenterol. , vol.46 , pp. 468-481
    • Guarner, F.1    Khan, A.G.2    Garisch, J.3
  • 16
    • 84860708876 scopus 로고    scopus 로고
    • Probiotics for the prevention and treatment of antibiotic-associated diarrhea: A systematic review and meta-analysis
    • Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307:1959-1969.
    • (2012) JAMA. , vol.307 , pp. 1959-1969
    • Hempel, S.1    Newberry, S.J.2    Maher, A.R.3
  • 17
    • 84871349683 scopus 로고    scopus 로고
    • Probiotics for the prevention of Clostridium difficile -associated diarrhea: A systematic review and meta-analysis
    • Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile -associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 2012;157:878-888.
    • (2012) Ann Intern Med. , vol.157 , pp. 878-888
    • Johnston, B.C.1    Ma, S.S.2    Goldenberg, J.Z.3
  • 18
    • 85038444044 scopus 로고    scopus 로고
    • Probiotics for the prevention of Clostridium difficile -associated diarrhea in adults and children
    • Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics for the prevention of Clostridium difficile -associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.
    • (2013) Cochrane Database Syst Rev. , vol.5
    • Goldenberg, J.Z.1    Ma, S.S.2    Saxton, J.D.3
  • 19
    • 84889608780 scopus 로고    scopus 로고
    • A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: A multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE)
    • Allen SJ, Wareham K, Wang D, et al. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess. 2013;17:1-140.
    • (2013) Health Technol Assess. , vol.17 , pp. 1-140
    • Allen, S.J.1    Wareham, K.2    Wang, D.3
  • 20
    • 84891614402 scopus 로고    scopus 로고
    • Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections
    • Shan LS, Hou P, Wang ZJ, et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes. 2013;4:329-334.
    • (2013) Benef Microbes. , vol.4 , pp. 329-334
    • Shan, L.S.1    Hou, P.2    Wang, Z.J.3
  • 21
    • 84894186045 scopus 로고    scopus 로고
    • A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: A randomised controlled trial
    • Wong S, Jamous A, O'Driscoll J, et al. A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial. Br J Nutr. 2014;111:672-678.
    • (2014) Br J Nutr. , vol.111 , pp. 672-678
    • Wong, S.1    Jamous, A.2    O’Driscoll, J.3
  • 22
    • 84891625369 scopus 로고    scopus 로고
    • Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study
    • Ouwehand AC, DongLian C, Weijian X, et al. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine. 2014;32:458-463.
    • (2014) Vaccine. , vol.32 , pp. 458-463
    • Ouwehand, A.C.1    DongLian, C.2    Weijian, X.3
  • 23
    • 0000795948 scopus 로고
    • Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis
    • Hall IC, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child. 1935;49:390-402.
    • (1935) Am J Dis Child. , vol.49 , pp. 390-402
    • Hall, I.C.1    O'Toole, E.2
  • 25
    • 67649391053 scopus 로고    scopus 로고
    • Clostridium difficile infection: New developments in epidemiology and pathogenesis
    • Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7:526-536.
    • (2009) Nat Rev Microbiol. , vol.7 , pp. 526-536
    • Rupnik, M.1    Wilcox, M.H.2    Gerding, D.N.3
  • 26
    • 84912046394 scopus 로고    scopus 로고
    • Clostridium difficile infection: Update on diagnosis, epidemiology, and treatment strategies
    • To KB, Napolitano LM. Clostridium difficile infection: update on diagnosis, epidemiology, and treatment strategies. Surg Infect (Larchmt). 2014;15:490-502.
    • (2014) Surg Infect (Larchmt). , vol.15 , pp. 490-502
    • To, K.B.1    Napolitano, L.M.2
  • 27
    • 84908178824 scopus 로고    scopus 로고
    • The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010
    • Reveles KR, Lee GC, Boyd NK, Frei CR. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. Am J Infect Control. 2014;42:1028-1032.
    • (2014) Am J Infect Control. , vol.42 , pp. 1028-1032
    • Reveles, K.R.1    Lee, G.C.2    Boyd, N.K.3    Frei, C.R.4
  • 28
    • 77951026738 scopus 로고    scopus 로고
    • Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)
    • Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-455.
    • (2010) Infect Control Hosp Epidemiol. , vol.31 , pp. 431-455
    • Cohen, S.H.1    Gerding, D.N.2    Johnson, S.3
  • 29
    • 25144469664 scopus 로고    scopus 로고
    • Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
    • Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079-1084.
    • (2005) Lancet. , vol.366 , pp. 1079-1084
    • Warny, M.1    Pepin, J.2    Fang, A.3
  • 30
    • 84871990888 scopus 로고    scopus 로고
    • Emergence and global spread of epidemic healthcare-associated Clostridium difficile
    • He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2013;45:109-113.
    • (2013) Nat Genet. , vol.45 , pp. 109-113
    • He, M.1    Miyajima, F.2    Roberts, P.3
  • 31
    • 84870168265 scopus 로고    scopus 로고
    • Preventing Clostridium difficile infection in the intensive care unit
    • Zilberberg MD, Shorr AF. Preventing Clostridium difficile infection in the intensive care unit. Crit Care Clin. 2013;29:11-18.
    • (2013) Crit Care Clin. , vol.29 , pp. 11-18
    • Zilberberg, M.D.1    Shorr, A.F.2
  • 32
    • 77957376775 scopus 로고    scopus 로고
    • Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production
    • Merrigan M, Venugopal A, Mallozzi M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010;192:4904-4911.
    • (2010) J Bacteriol. , vol.192 , pp. 4904-4911
    • Merrigan, M.1    Venugopal, A.2    Mallozzi, M.3
  • 33
    • 84922032670 scopus 로고    scopus 로고
    • The potential for emerging therapeutic options for Clostridium difficile infection
    • Mathur H, Rea MC, Cotter PD, Ross RP, Hill C. The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes. 2014;5:696-710.
    • (2014) Gut Microbes. , vol.5 , pp. 696-710
    • Mathur, H.1    Rea, M.C.2    Cotter, P.D.3    Ross, R.P.4    Hill, C.5
  • 34
    • 84926417736 scopus 로고    scopus 로고
    • Randomised clinical trial: Faecal microbiota transplantation by colonoscopy vs vancomycin for the treatment of recurrent Clostridium difficile infection
    • Cammarota G, Masucci L, Ianiro G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015;41:835-843.
    • (2015) Aliment Pharmacol Ther. , vol.41 , pp. 835-843
    • Cammarota, G.1    Masucci, L.2    Ianiro, G.3
  • 35
    • 84947125813 scopus 로고    scopus 로고
    • Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead
    • Borody T, Fischer M, Mitchell S, Campbell J. Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead. Expert Rev Gastroenterol Hepatol. 2015;9(11):1379-1391.
    • (2015) Expert Rev Gastroenterol Hepatol , vol.9 , Issue.11 , pp. 1379-1391
    • Borody, T.1    Fischer, M.2    Mitchell, S.3    Campbell, J.4
  • 36
    • 84900418033 scopus 로고    scopus 로고
    • Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: A randomized, open-label, controlled pilot study
    • Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014;58:1515-1522.
    • (2014) Clin Infect Dis. , vol.58 , pp. 1515-1522
    • Youngster, I.1    Sauk, J.2    Pindar, C.3
  • 37
    • 58849144336 scopus 로고    scopus 로고
    • The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile -associated diarrhea
    • Rohde CL, Bartolini V, Jones N. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile -associated diarrhea. Nutr Clin Pract. 2009;24:33-40.
    • (2009) Nutr Clin Pract. , vol.24 , pp. 33-40
    • Rohde, C.L.1    Bartolini, V.2    Jones, N.3
  • 38
    • 62149117549 scopus 로고    scopus 로고
    • Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors
    • Jones SE, Versalovic J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol. 2009;9:35.
    • (2009) BMC Microbiol. , vol.9 , pp. 35
    • Jones, S.E.1    Versalovic, J.2
  • 39
    • 84924921458 scopus 로고    scopus 로고
    • Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: Systematic review and meta-analysis
    • Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1547-1561.
    • (2014) Am J Gastroenterol. , vol.109 , pp. 1547-1561
    • Ford, A.C.1    Quigley, E.M.2    Lacy, B.E.3
  • 40
    • 84893687483 scopus 로고    scopus 로고
    • Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: Meta-analysis of randomized controlled trials
    • Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014;20:21-35.
    • (2014) Inflamm Bowel Dis. , vol.20 , pp. 21-35
    • Shen, J.1    Zuo, Z.X.2    Mao, A.P.3
  • 41
    • 84855826006 scopus 로고    scopus 로고
    • A meta-analysis and systematic review on the effect of probiotics in acute diarrhea
    • Salari P, Nikfar S, Abdollahi M. A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allergy Drug Targets. 2012;11:3-14.
    • (2012) Inflamm Allergy Drug Targets. , vol.11 , pp. 3-14
    • Salari, P.1    Nikfar, S.2    Abdollahi, M.3
  • 42
    • 29244491643 scopus 로고    scopus 로고
    • Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication
    • Duman DG, Bor S, Ozutemiz O, et al. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. Eur J Gastroenterol Hepatol. 2005;17:1357-1361.
    • (2005) Eur J Gastroenterol Hepatol. , vol.17 , pp. 1357-1361
    • Duman, D.G.1    Bor, S.2    Ozutemiz, O.3
  • 44
    • 0034839847 scopus 로고    scopus 로고
    • Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: A randomized, placebo-controlled trial
    • Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc. 2001;76: 883-889.
    • (2001) Mayo Clin Proc. , vol.76 , pp. 883-889
    • Thomas, M.R.1    Litin, S.C.2    Osmon, D.R.3    Corr, A.P.4    Weaver, A.L.5    Lohse, C.M.6
  • 45
    • 38649108836 scopus 로고    scopus 로고
    • Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled trial
    • Beausoleil M, Fortier N, Guenette S, et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol. 2007;21:732-736.
    • (2007) Can J Gastroenterol. , vol.21 , pp. 732-736
    • Beausoleil, M.1    Fortier, N.2    Guenette, S.3
  • 46
    • 34547569295 scopus 로고    scopus 로고
    • Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylor i therapy: A prospective randomized placebo-controlled double-blind study
    • Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylor i therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter. 2007;12:309-316.
    • (2007) Helicobacter. , vol.12 , pp. 309-316
    • Cindoruk, M.1    Erkan, G.2    Karakan, T.3    Dursun, A.4    Unal, S.5
  • 47
    • 75749114116 scopus 로고    scopus 로고
    • Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics
    • Lonnermark E, Friman V, Lappas G, Sandberg T, Berggren A, Adlerberth I. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol. 2010;44:106-112.
    • (2010) J Clin Gastroenterol. , vol.44 , pp. 106-112
    • Lonnermark, E.1    Friman, V.2    Lappas, G.3    Sandberg, T.4    Berggren, A.5    Adlerberth, I.6
  • 48
    • 0028985777 scopus 로고
    • Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo
    • McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol. 1995;90:439-448.
    • (1995) Am J Gastroenterol. , vol.90 , pp. 439-448
    • McFarland, L.V.1    Surawicz, C.M.2    Greenberg, R.N.3
  • 50
    • 0033229628 scopus 로고    scopus 로고
    • Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study
    • Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999;104:e64.
    • (1999) Pediatrics. , vol.104
    • Arvola, T.1    Laiho, K.2    Torkkeli, S.3
  • 51
    • 2942704185 scopus 로고    scopus 로고
    • Clostridium difficile pilot study: Effects of probiotic supplementation on the incidence of C. Difficile diarrhoea
    • Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol. 2004;7:59-62.
    • (2004) Int Microbiol. , vol.7 , pp. 59-62
    • Plummer, S.1    Weaver, M.A.2    Harris, J.C.3    Dee, P.4    Hunter, J.5
  • 52
    • 15044347921 scopus 로고    scopus 로고
    • Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: A randomized double-blind placebo-controlled trial
    • Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005;21:583-590.
    • (2005) Aliment Pharmacol Ther. , vol.21 , pp. 583-590
    • Kotowska, M.1    Albrecht, P.2    Szajewska, H.3
  • 53
    • 33645544410 scopus 로고    scopus 로고
    • Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: A prospective study
    • Can M, Besirbellioglu BA, Avci IY, Beker CM, Pahsa A. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit. 2006;12:I19-I22.
    • (2006) Med Sci Monit. , vol.12 , pp. I19-I22
    • Can, M.1    Besirbellioglu, B.A.2    Avci, I.Y.3    Beker, C.M.4    Pahsa, A.5
  • 54
    • 34447630803 scopus 로고    scopus 로고
    • Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: Randomised double blind placebo controlled trial
    • Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335:80.
    • (2007) BMJ. , vol.335 , pp. 80
    • Hickson, M.1    D'Souza, A.L.2    Muthu, N.3
  • 55
    • 58849147241 scopus 로고    scopus 로고
    • Prevention of Clostridium difficile (C-difficile) diarrhea with probiotic in hospitalized patients treated with antibiotics [abstract]
    • Rafiq R, Pandey D, Osman SM, Masood R, Donepudi I, Norkus E. Prevention of Clostridium difficile (C-difficile) diarrhea with probiotic in hospitalized patients treated with antibiotics [abstract]. Gastroenterology. 2007;132(Suppl 2):A187.
    • (2007) Gastroenterology , vol.132
    • Rafiq, R.1    Pandey, D.2    Osman, S.M.3    Masood, R.4    Donepudi, I.5    Norkus, E.6
  • 57
    • 44649140406 scopus 로고    scopus 로고
    • Clinical trial: Effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children
    • Ruszczynski M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther. 2008;28:154-161.
    • (2008) Aliment Pharmacol Ther. , vol.28 , pp. 154-161
    • Ruszczynski, M.1    Radzikowski, A.2    Szajewska, H.3
  • 58
    • 55949121333 scopus 로고    scopus 로고
    • Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans
    • Safdar N, Barigala R, Said A, McKinley L. Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans. J Clin Pharm Ther. 2008;33:663-668.
    • (2008) J Clin Pharm Ther. , vol.33 , pp. 663-668
    • Safdar, N.1    Barigala, R.2    Said, A.3    McKinley, L.4
  • 60
    • 77954424086 scopus 로고    scopus 로고
    • Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile -associated diarrhea prophylaxis in adult patients
    • Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile -associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105:1636-1641.
    • (2010) Am J Gastroenterol. , vol.105 , pp. 1636-1641
    • Gao, X.W.1    Mubasher, M.2    Fang, C.Y.3    Reifer, C.4    Miller, L.E.5
  • 61
    • 77949370649 scopus 로고    scopus 로고
    • Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea-a placebo controlled double-blind randomized, multi-center study
    • Sampalis J, Psaradellis E, Rampakakis E. Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea-a placebo controlled double-blind randomized, multi-center study. Arch Med Sci. 2010;6:56-64.
    • (2010) Arch Med Sci. , vol.6 , pp. 56-64
    • Sampalis, J.1    Psaradellis, E.2    Rampakakis, E.3
  • 62
    • 84861908072 scopus 로고    scopus 로고
    • Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: A single-center, randomized, double-blind, placebo-controlled trial
    • Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2012;107:922-931.
    • (2012) Am J Gastroenterol. , vol.107 , pp. 922-931
    • Pozzoni, P.1    Riva, A.2    Bellatorre, A.G.3
  • 63
    • 84878143512 scopus 로고    scopus 로고
    • Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial
    • Selinger CP, Bell A, Cairns A, Lockett M, Sebastian S, Haslam N. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. J Hosp Infect. 2013;84:159-165.
    • (2013) J Hosp Infect. , vol.84 , pp. 159-165
    • Selinger, C.P.1    Bell, A.2    Cairns, A.3    Lockett, M.4    Sebastian, S.5    Haslam, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.